|
RBM25 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.858600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.833020E-01 |
| Normal-vs-Stage2 |
1.663210E-01 |
| Normal-vs-Stage3 |
3.656100E-02 |
| Normal-vs-Stage4 |
1.842340E-02 |
| Stage1-vs-Stage2 |
6.329400E-01 |
| Stage1-vs-Stage3 |
2.438200E-01 |
| Stage1-vs-Stage4 |
2.167200E-01 |
| Stage2-vs-Stage3 |
7.485000E-01 |
| Stage2-vs-Stage4 |
3.923600E-01 |
| Stage3-vs-Stage4 |
4.321200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.529600E-01 |
| Normal-vs-AfricanAmerican |
2.368000E-01 |
| Normal-vs-Asian |
7.946000E-01 |
| Caucasian-vs-AfricanAmerican |
9.089800E-01 |
| Caucasian-vs-Asian |
7.694200E-01 |
| AfricanAmerican-vs-Asian |
7.233000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.242990E-01 |
| Normal-vs-Female |
6.330400E-01 |
| Male-vs-Female |
3.081600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.522800E-01 |
| Normal-vs-Extreme_Weight |
4.391800E-02 |
| Normal-vs-Obese |
4.794000E-01 |
| Normal-vs-Extreme_Obese |
9.460400E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.506800E-01 |
| Normal_Weight-vs-Obese |
7.461400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.214800E-01 |
| Extreme_Weight-vs-Obese |
1.920170E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.808600E-01 |
| Obese-vs-Extreme_Obese |
3.158400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.448400E-01 |
| Normal-vs-Age(41-60Yrs) |
8.585800E-01 |
| Normal-vs-Age(61-80Yrs) |
3.477500E-02 |
| Normal-vs-Age(81-100Yrs) |
4.361700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.917800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.481440E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.237570E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.966360E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.583600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.785610E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.013800E-01 |
| Normal-VS-Type2 PRCC |
4.26540000000308E-05 |
| Normal-VS-KIRP CIMP |
3.819400E-01 |
| Normal-VS-Unclassified PRCC |
3.916800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.77249999958151E-07 |
| Type1 PRCC-VS-KIRP CIMP |
5.677400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.960400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.408000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.322340E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.712800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.760130E-03 |
| Normal-vs-N1 |
6.484200E-01 |
| Normal-vs-N2 |
1.397850E-02 |
| N0-vs-N1 |
3.104400E-02 |
| N0-vs-N2 |
2.323600E-01 |
| N1-vs-N2 |
7.476400E-02 |
|
|
